SEC Form 4 · accession 0001225208-16-025410
Nobilis Health Corp. · HLTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry Joseph Fleming
Officer — Chief Executive Officer · Director
Period of report
Feb 2, 2016
Accepted (ET)
Feb 2, 2016 · 1:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001409916
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| CommonF1 | Feb 2, 2016 | P | 10,000 | $2.1951 | A | 2,707,955 | D | |
| Common | holding | — | — | — | 7,500 | I | Held by Adult Son, Brendon Fleming | |
| Common | holding | — | — | — | 5,000 | I | Held by Adult Son, Grady Fleming | |
| Common | holding | — | — | — | 5,000 | I | Held by Adult Son, Sean Fleming |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.185 to $2.20, inclusive. The reporting person undertakes to provide to Nobilis Health Corp., any security holder of Nobilis Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.